ARS Pharmaceuticals Inc
NASDAQ:SPRY
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Price:
7.815
USD
-3.16%
Market Closed
Market Cap:
$772.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ARS Pharmaceuticals Inc
NASDAQ:SPRY
|
US |
|
Dosni Roha Indonesia Tbk PT
IDX:ZBRA
|
ID |
|
Accel SAB de CV
BMV:ACCELSAB
|
MX |
|
Indian Hotels Company Ltd
NSE:INDHOTEL
|
IN |
|
Oxford Metrics PLC
LSE:OMG
|
UK |
|
Lixiang Education Holding Co Ltd
NASDAQ:LXEH
|
CN |
|
Alpha Capital Acquisition Co
NASDAQ:ASPC
|
KY |
|
Hanil Iron & Steel Co Ltd
KRX:002220
|
KR |
|
A
|
ADC India Communications Ltd
BSE:523411
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
SPRY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 7.815 USD,
ARS Pharmaceuticals Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SPRY Multiples-Based Value
LOCKED
Multiples Across Competitors
SPRY Competitors Multiples
ARS Pharmaceuticals Inc Competitors
ARS Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
ARS Pharmaceuticals Inc
NASDAQ:SPRY
|
776m USD | 9.2 | -4.5 | -3.5 | -3.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.5 | 21.4 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.2 | 35 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
